We use cookies to improve your experience on VidNexa. Learn more
Cookie preferences
We use cookies to improve your experience on VidNexa. We use necessary cookies to keep you signed in and keep the site secure, and — only with your permission — preference cookies (seen videos, recent categories), analytics cookies (a first-party visitor id and A/B assignment, first-party measurement, and Google Analytics), and marketing cookies (only when a third-party ad tag or slot is enabled).
Learn more
Choose which non-essential cookies VidNexa may use. Necessary cookies are always on: they keep you signed in, protect forms, and keep the site secure.
Global Privacy Control: your browser is sending a GPC signal, so Analytics and Marketing stay off while it is on — even if you previously accepted them.
NecessarySession, feed security nonce, admin sign-in persistence. Always on.
PreferencesSeen-video list, recent categories, row preferences. Remember what you watched and browsed.
AnalyticsGoogle Analytics (GA4), run by Google, to measure traffic — it loads only if you allow this category — plus a first-party visitor id, A/B assignment and first-party viewing measurement used to test feed changes. Turning this off also deletes Google Analytics cookies already set.
MarketingThird-party ad tags and slots, only when an admin enables them. No marketing cookie is set by default.
Almost one in three deaths in Singapore is due to heart diseases or stroke. Despite cardiovascular conditions affecting Asian patients differently, much of what…
Almost one in three deaths in Singapore is due to heart diseases or stroke. Despite cardiovascular conditions affecting Asian patients differently, much of what we know about the disease has been shaped by animal models and Western populations. Singapore’s new Centre for Integrative Human Cell Research and Translation (CIPHER) is aiming to close that gap. CNA speaks to Assistant Professor Chrishan Ramachandra, deputy director of CIPHER.
...more
4 Comments
@@TimothyTCJImported2wk ago
Another misleading stats? 1 in 3 probably includes those who 'passed peacefully' during old age just because their hearts have stopped since there is no medical cause of death as die of old age.
@@maju.portalImported2wk ago
It is clear that these public research boards completely lack the risk management of real business entrepreneurs. Blindly throwing massive capital at speculative breakthroughs without transparent baseline targets is a structural failure. Regular citizens shouldn't be the ones absorbing the losses through constant tax hikes when projects stall.<br>"Sort by Newest" to read more interesting comments.
@@maju.portalImported2wk ago
The cancellation of the driverless bus trials this month shows exactly why these massive research budgets need stricter accountability. In the real business world, spending billions for over a decade with no practical utility for regular taxpayers would get people fired. We need much stronger independent checks in place to enforce clear project timelines and stop socializing the financial downside onto everyday citizens.<br>"Sort by Newest" to read more interesting comments.
@@maju.portalImported2wk ago
Singaporeans need to look past the technical buzzwords and examine the structural flaws in our national spending priorities. While everyday citizens face punishing GST hikes and structural inflation under the banner of fiscal prudence, the state has systematically committed an astronomical S$65 billion across the last two five-year research cycles (RIE2025 and RIE2030).<br><br>Look at the massive budgets directed into biomedical and health research—including a multi-billion-dollar chunk of the S$10.8 billion strategic pillar handed over for genomic sequencing and abstract lab models like CIPHER. This follows the exact same pattern as the autonomous vehicle (AV) sector. After 11 years of continuous road trials and an estimated S$1.2 billion to S$1.5 billion allocated to AV development since 2015, the LTA just officially halted its planned driverless public bus pilots this month because the technology remains unviable for complex public routes. In the commercial world, burning through multi-billion-dollar budgets for over a decade without delivering practical utility is completely abnormal—the executives responsible would have been long fired. Yet, our public administration operates without this disciplined market accountability. Lacking the sharp commercial risk management of real entrepreneurs, they engage in blind investing and wishful thinking, chasing hypothetical breakthroughs without transparent baseline limits, knowing that the financial downside of these failed experiments will ultimately be socialized onto the tax-paying public.<br><br>The reality shows a persistent gap between expensive promises—like a Swiss standard of living or functional AV fleets—and the actual day-to-day returns for local citizens, even with free trade agreements and foreign talent frameworks in place. The average Singaporean sees no tangible, near-term returns from these elite capital deployments—only a rising cost of living and higher tax burdens, while critical demographic crises like our record-low TFR remain structurally underfunded. When multi-billion-dollar sums are expended with nothing to show, the system desperately needs strict accountability. To improve this, Singaporeans must do what they can to help the government make good and sound policies by voting more Opposition into Parliament. A stronger alternative presence will assist in enforcing strict, independent oversight—demanding clear timelines, mandatory waypoints, and verifiable projections of direct public benefits before these massive outlays are ever approved.
Almost one in three deaths in Singapore is due to heart diseases or stroke. Despite cardiovascular conditions affecting Asian patients differently, much of what we know about the disease has been shaped by animal models and Western populations. Singapore’s new Centre for Integrative Human Cell Research and Translation (CIPHER) is aiming to close that gap. CNA speaks to Assistant Professor Chrishan Ramachandra, deputy director of CIPHER.
Share
Heart disease research: CIPHER dedicated to cardiovascular stem cell research for Asian biology
Kimberly Howard • 1.4K views
Share via
Or copy link
Embed
Report video
Reporting your own copyrighted work? Rights holders: please use the DMCA takedown form — it goes straight to our copyright agent.
Send a thanks
Support the creator with a one-time donation.
Choose an amount — you'll continue to secure checkout to complete your Thanks.